Poor Reporting of Quality of Life Outcomes in Dermatology Randomized Controlled Clinical Trials

Abstract

BACKGROUND: Because many dermatological diseases are chronic but not life-threatening, consideration of their impact on health-related quality of life (QOL) seems essential. OBJECTIVE: To analyze the use of QOL as an evaluation endpoint in randomized clinical trials concerning skin diseases. METHODS: Studies identified by computerized search of 3 bibliographical databases were selected, and their data on QOL as an evaluation endpoint were collected and analyzed. RESULTS: Among the 67 studies retained, 87% did not adequately describe the questionnaires; 75% did not address handling of missing data; 95% did not calculate the number of subjects needed to obtain the desired statistical power; 95% did not disclose before-and-after results as means of overall scores and each dimension. CONCLUSION: Our analysis highlighted methodological weaknesses in the use of QOL questionnaire and poor reporting of QOL outcomes in randomized clinical trials.